Transcatheter Aortic Valve Implantation (TAVI) Market: Growth & Revenue Opportunities by Top Key Players Abbott Laboratories, Boston Scientific Corporation (Symetis SA), Bracco S.p.A. (HLT, Inc.) and more

Allied Market Research recently published a report, titled, “Transcatheter Aortic Valve Implantation (TAVI) Market by Procedure (Transfemoral Implantation, Transapical Implantation, and Transaortic Implantation) - Global Opportunity Analysis and Industry Forecast, 2018-2025”. According to the report, the global transcatheter aortic valve implantation (TAVI) market was pegged $2.76 billion in 2017 and is estimated to reach $8.14 billion by 2025, registering CAGR of 13.8% during the forecast period.

Increased prevalence of aortic stenosis coupled with rise in geriatric population and high adoption rate for transcatheter aortic valve implantation procedure have boosted the growth of the TAVI market.

In addition, increase in clinical evidence of safety and efficacy and new device approvals and rise in number of TAVR center supplemented the market growth. However, high cost of the devices and stringent regulatory approval process coupled with unfavorable reimbursement policies hinders the market growth. On the contrary, use of TAVI systems for new indications, rise in healthcare expenditure of developing countries, and increase in interest of local to global players in the TAVI market are expected to create lucrative opportunities for the market players in the near future.

Key players have adopted product approval as their key strategy to enhance their product offerings by expanding the usage of transcatheter aortic valves for new indications, such as intermediate risk aortic stenosis patients.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/1675?utm_source=sy-Openpr

The key players profiled in this report include
• Abbott Laboratories
• Boston Scientific Corporation (Symetis SA)
• Bracco S.p.A. (HLT Inc.)
• Edwards Lifesciences Corporation
• JenaValve Technology Inc.
• JC Medical Inc.
• Medtronic plc
• Meril Life Sciences Pvt. Ltd.
• NVT AG
• Venus Medtech Inc.

The report segments the TAVI market based on the approach used for implantation. Mainly, three types of approaches are used to implant the transcatheter aortic valve in patients-transfemoral, transapical, and transaortic implantation.

Transfemoral implantation was the highest revenue-generating segment in the global market (in terms of value and volume) in 2017, as it does not require a chest incision. Furthermore, transaortic segment is projected to grow at the highest CAGR of 19.1% (in terms of value) and 20.1% (in terms of volume) by 2025, due to positive outcomes of several clinical trials.

Get Discount UP To 25% on this Report * Offer Till 31st Dec 2018@ https://www.alliedmarketresearch.com/purchase-enquiry/1675?utm_source=sy-Openpr

Key Findings of the Transcatheter Aortic Valve Implantation (TAVI) Market:
• In 2017, transfemoral implantation generated the highest revenue, and is projected to grow at a CAGR of 13.2% (in terms of value) during the forecast period.
• Both in terms of value and volume, the Europe TAVI market is expected to maintain its leading position during the forecast period.
• Asia-Pacific is expected to be the fastest growing region, and is expected to grow with a CAGR of 18.6% (in terms of value) from 2018 to 2025.
• Germany was the leading country whereas the UK is projected to be the fastest growing country in the Europe TAVI market.
• India is the fastest growing country in the Asia-Pacific TAVI market and is expected to grow at a CAGR of 29.8% (in terms of revenue) from 2018 to 2025.

Europe accounted for a major share in the global TAVI market (in terms of value and volume) in 2017, and is expected to maintain this trend. This is attributed to the rise in prevalence of severe aortic stenosis cases coupled with the increase in population of inoperable patients, and high adoption rate of advanced transcatheter aortic valves.

However, Asia-Pacific is estimated to grow at a high CAGR (in terms of value and volume) throughout the analysis period, owing to the presence of ample growth opportunities in terms of unmet medical needs for the treatment of aortic stenosis and increase in awareness about TAVI procedures among physicians.

Access Full Summery @ https://www.alliedmarketresearch.com/tavi-market?utm_source=sy-Openpr

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

Web: www.alliedmarketresearch.com

This release was published on openPR.